Personal information

Other IDs

Scopus Author ID: 57193860429
Scopus Author ID: 57524245300
ResearcherID: AAF-8317-2019
Loop profile: 2384669

Activities

Collapse all

Employment (2)

Organon & Co: Jersey City, NJ, US

2022-11 to present
Employment
Source: Self-asserted source
Daisuke Goto

Merck & Co Inc - Rahway: Rahway, NJ, US

2018 to 2022
Employment
Source: Self-asserted source
Daisuke Goto

Education and qualifications (1)

Rutgers, The State University of New Jersey: New Brunswick, New Jersey, US

2014 | Ph.D.
Education
Source: Self-asserted source
Daisuke Goto

Works (11)

Experiencing chronic cough symptoms for 3 years is associated with increased rates of healthcare resource use and higher healthcare costs in the United States compared to resolved chronic cough

Current Medical Research and Opinion
2025-01-02 | Journal article
DOI: 10.1080/03007995.2024.2433252
Contributors: Xuehua Ke; Helen Ding; Yezhou Sun; Daisuke Goto; Prajakta Waghmare; Mingyue Li
Source: check_circle
Crossref

Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma

Frontiers in Oncology
2024 | Journal article
DOI: 10.3389/fonc.2024.1348045
EID:

2-s2.0-85185494807

Part of ISSN: 2234943X
Contributors: Black, C.M.; Zheng, D.; Hair, G.M.; Ai, L.; Wang, L.; Goto, D.; Lerman, N.; Bidadi, B.; Hanna, G.J.
Source: Self-asserted source
Daisuke Goto via Scopus - Elsevier

Effectiveness of the etonogestrel subdermal implant in users with overweight and obesity: a systematic literature review

BMJ Sexual & Reproductive Health
2024-10-26 | Journal article
DOI: 10.1136/bmjsrh-2024-202424
Contributors: Daisuke Goto; John W Grunden; Moritz Klinghardt; Vanessa Perez Patel; Sophia von Stockum; Clare Barnett; Johannes Bitzer
Source: check_circle
Crossref

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1160144
EID:

2-s2.0-85161072959

Part of ISSN: 2234943X
Contributors: Black, C.M.; Hanna, G.J.; Wang, L.; Ramakrishnan, K.; Goto, D.; Turzhitsky, V.; Hair, G.M.
Source: Self-asserted source
Daisuke Goto via Scopus - Elsevier
grade
Preferred source (of 3)‎

Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States

European Journal of Heart Failure
2022 | Journal article
DOI: 10.1002/ejhf.2727
EID:

2-s2.0-85142160643

Part of ISSN: 18790844 13889842
Contributors: Greene, S.J.; Goto, D.; Wang, D.; Hilkert, R.; Lautsch, D.; Fonarow, G.C.
Source: Self-asserted source
Daisuke Goto via Scopus - Elsevier

Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019

Vaccine
2022-09 | Journal article
DOI: 10.1016/j.vaccine.2022.06.048
Contributors: Janetta Catharina de Beer; Daisuke Goto; Helen Miller-Janson; Ryan Holl; Goran Bencina
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network

Translational Medicine Communications
2020-01 | Journal article
DOI: 10.1186/s41231-020-00057-y
Part of ISSN: 2396-832X
Source: Self-asserted source
Daisuke Goto

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data

Cancer Medicine
2020-01 | Journal article
DOI: 10.1002/cam4.2698
Contributors: Daisuke Goto; Rahul Khairnar; Jean A. Yared; Candice Yong; Dorothy Romanus; Eberechukwu Onukwugha; Julia F. Slejko
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network

Genetics in Medicine
2019 | Journal article
DOI: 10.1038/s41436-018-0080-y
EID:

2-s2.0-85049676333
Contributors: Levy, K.D.; Blake, K.; Fletcher-Hoppe, C.; Franciosi, J.; Goto, D.; Hicks, J.K.; Holmes, A.M.; Kanuri, S.H.; Madden, E.B.; Musty, M.D. et al.
Source: Self-asserted source
Daisuke Goto via Scopus - Elsevier
grade
Preferred source (of 3)‎

Querying stakeholders to inform comparative effectiveness research

Journal of Comparative Effectiveness Research
2017 | Journal article
DOI: 10.2217/cer-2016-0082
EID:

2-s2.0-85018935373
Contributors: Hong, Y.D.; Goto, D.; Mullins, C.D.
Source: Self-asserted source
Daisuke Goto via Scopus - Elsevier

Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis

PharmacoEconomics
2017-07 | Journal article
DOI: 10.1007/s40273-017-0505-5
Contributors: Daisuke Goto; Ya-Chen Tina Shih; Pascal Lecomte; Melvin Olson; Chukwukadibia Udeze; Yujin Park; C. Daniel Mullins
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Peer review (27 reviews for 9 publications/grants)

Review activity for Advanced drug delivery reviews. (2)
Review activity for Frontiers in pharmacology. (1)
Review activity for Health services research. (2)
Review activity for Journal of comparative effectiveness research. (1)
Review activity for PharmacoEconomics. (2)
Review activity for PLoS medicine. (3)
Review activity for Value in health regional issues. (13)
Review activity for Value in health. (2)
Review activity for World journal of oncology. (1)
How many people are using ORCID?